Martin Brecher

5.3k total citations · 1 hit paper
74 papers, 3.9k citations indexed

About

Martin Brecher is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Martin Brecher has authored 74 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Psychiatry and Mental health, 25 papers in Pharmacology and 6 papers in Cognitive Neuroscience. Recurrent topics in Martin Brecher's work include Schizophrenia research and treatment (51 papers), Bipolar Disorder and Treatment (33 papers) and Treatment of Major Depression (25 papers). Martin Brecher is often cited by papers focused on Schizophrenia research and treatment (51 papers), Bipolar Disorder and Treatment (33 papers) and Treatment of Major Depression (25 papers). Martin Brecher collaborates with scholars based in United States, Sweden and United Kingdom. Martin Brecher's co-authors include Björn Paulsson, Christopher Clyde, J. Napolitano, Dilip V. Jeste, Ira R. Katz, Jacobo Mintzer, Henri Begleiter, Jamie Mullen, Trisha Suppes and Eduard Vieta and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

Martin Brecher

71 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia

1999 578 citations Ira R. Katz, Dilip V. Jeste et al. The Journal of Clinical Psychiatry profile →

Peers

Countries citing papers authored by Martin Brecher

Since Specialization

Citations

This map shows the geographic impact of Martin Brecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Brecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Brecher more than expected).

Fields of papers citing papers by Martin Brecher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Brecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Brecher. The network helps show where Martin Brecher may publish in the future.

Co-authorship network of co-authors of Martin Brecher

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Brecher. A scholar is included among the top collaborators of Martin Brecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Brecher. Martin Brecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I) 2010 ·The Journal of Clinical Psychiatry ·Allan H. Young, Susan L. McElroy, Michael Bauer, (unknown), William Chang, Bengt Olausson, Björn Paulsson, Martin Brecher, (unknown)	232
2	Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression 2010 ·Journal of Affective Disorders ·David E. Kemp, Stephen J. Ganocy, Martin Brecher, Berit X. Carlson, (unknown), James M. Eudicone, G. Evoniuk, (unknown), Andrew C. Leon, Margaret Minkwitz, (unknown), Hans H. Stassen, Armin Szegedi, Mauricio Tohen, A. P. P. van Willigenburg, Joseph R. Calabrese	44
3	Safety and tolerability of once‐daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double‐blind, placebo‐controlled studies 2010 ·Human Psychopharmacology Clinical and Experimental ·Didier Meulien, Karin Huizar, Martin Brecher	20
4	A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II) 2010 ·The Journal of Clinical Psychiatry ·Susan L. McElroy, Richard H. Weisler, William Chang, Bengt Olausson, Björn Paulsson, Martin Brecher, (unknown), Charles Merideth, A. Nordenhem, Allan H. Young, (unknown)	227
5	A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone 2009 ·The Journal of Clinical Psychiatry ·John W. Newcomer, Robert E. Ratner, Jan W. Eriksson, Robin Emsley, Didier Meulien, Frank Miller, (unknown), Rupert W. Leong, Martin Brecher	49
6	Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127) 2009 ·American Journal of Psychiatry ·Trisha Suppes, Eduard Vieta, Sherry Liu, Martin Brecher, Björn Paulsson, (unknown)	151
7	Once-daily extended release quetiapine fumarate (quetiapine XR) as adjunct to) antidepressant therapy fit patients with major depressive disorder 2008 ·The International Journal of Neuropsychopharmacology ·E. Constant, (unknown), Willie Earley, Peter Lindgren, Martin Brecher, Michael Bauer	4
8	Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126) 2008 ·Journal of Affective Disorders ·Eduard Vieta, Trisha Suppes, Ivan Eggens, Inger Persson, Björn Paulsson, Martin Brecher	157
9	Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release 2008 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·(unknown), Martin Brecher, (unknown), Helen Winter	85
10	Treatment of agitation and aggression in bipolar mania: Efficacy of quetiapine 2007 ·Journal of Affective Disorders ·P.F. Buckley, Björn Paulsson, Martin Brecher	15
11	Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies 2005 ·Current Medical Research and Opinion ·Eduard Vieta, Jamie Mullen, Martin Brecher, Björn Paulsson, Martin Jones	89
12	Rapid Dose Escalation With Quetiapine 2005 ·Journal of Clinical Psychopharmacology ·Mark A. Smith, Robin McCoy, (unknown), Martin Brecher	21
13	Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia 2004 ·International Clinical Psychopharmacology ·Siegfried Kasper, Martin Brecher, (unknown), (unknown)	23
14	The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia 2000 ·International Journal of Psychiatry in Clinical Practice ·Martin Brecher, Ihor W Rak, Kelly Melvin, (unknown)	77
15	A combined analysis of double‐blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms 1999 ·Acta Psychiatrica Scandinavica ·(unknown), Martin Brecher, (unknown)	69
16	Psychopharmacology of Atypical Antipsychotics and Clinical Outcomes in Elderly Patients 1999 ·The Journal of Clinical Psychiatry ·(unknown), Martin Brecher	10
17	Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia breakdown → 1999 ·The Journal of Clinical Psychiatry ·Ira R. Katz, Dilip V. Jeste, Jacobo Mintzer, Christopher Clyde, J. Napolitano, Martin Brecher, (unknown)	578
18	Prolactin Levels and Adverse Events in Patients Treated with Risperidone 1999 ·Journal of Clinical Psychopharmacology ·David L. Kleinberg, John M. Davis, R. De Coster, B. Van Baelen, Martin Brecher	242
19	A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial 1997 ·Psychopharmacology ·Dilip V. Jeste, Mark A. Klausner, Martin Brecher, Christopher Clyde, (unknown)	22
20	Nursing Home Research From Industry’s Perspective 1997 ·International Psychogeriatrics ·Martin Brecher	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact